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Abstract 
Background: The intersecting clinicopathological features and histological patterns, including 
cribriform, tubular and solid patterns of adenoid cystic carcinoma (ACC) and polymorphous low-grade 
adenocarcinoma (PLGA) may end in a problematic diagnosis .ACC has a worse prognosis than  PLGA 
making distinction important for therapeutic and prognostic purposes . The Aims of this study were to 
evaluate the immunohistochemical expression of CD105 and Ki-67 in adenoid cystic carcinoma and 
polymorphous low grade adeoncarcinoma of the salivary glands and to correlate the 
immunoexpression of these proteins with the clinicopathological findings. 
Materials and methods 
In this retrospective study , fifty  of archival formalin fixed paraffin embedded tissue samples of 
salivary gland malignancies  were used,  twenty five  blocks of  adenoid cystic carcinomas   and 
twenty five  blocks of  polymorphous low grade adenocarcinoma obtained from the archives of the 
department of oral pathology / college of dentistry / Baghdad university, Al-Shaheed Ghazi hospital, 
were included  in our study. Four micrometer sections gained and immunostained using monoclonal 
antibody against CD105 and Ki-67. The immunoexpression was identified  by the presence of brown 
stain in the cytoplasm of tumor cell in CD105 and the presence of brown stain in the nucleus  of tumor 
cell in Ki-67. The proportion of cells that expressed the stain was correlated with the 
clinicopathological data of the patients. 
Results: C D 1 0 5  expression was found positive in 21 cases of A C C  and 2 0 c a s e s  o f  
PLGA localized in tumor cells. 
 a n d K i - 6 7  expression was found positive in 24 cases of A C C  and 2 3  c a s e s o f  PLGA 
localized in tumor cells. 
Non- significant  statistical  relation  (P=0.801) was  detected  regarding CD105  expression  in  both  
types  of  tumor and non- significant  statistical  relation (P= 0.852) was detected  regarding Ki-67 
expression in both types of tumor .  
Non- significant  statistical  relation  (P=>0.05) was  detected  regarding CD105 and Ki-67 
expression  in relation to sex, site and stage in  both  types  of  tumor. 
Conclusion: Weak expression CD105 and  Ki-67 in ACC and PLGA  might be explained by CD105 
and  Ki-67 did  not represent an exclusive factors consequently; other factors might be involved in the 
proliferation, progression and  metastasis of both tumor types. 
Key words: Adenoid cystic carcinoma, Polymorphous low grade adenocarcinoma , immunohistochemistry, 
CD105 and Ki-67.   
 
Introduction 
Adenoid cystic carcinoma (ACC) is a malignant neoplasm of modified 
myoepithelial and ductal cells that affect  both the major and minor salivary glands. 
Distinctive cribriform, tubular, and solid growth patterns are the most important 
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characteristic features of ACC. Malignant transformation of the intercalated duct 
reverse cells leading to ACC occurrence   and  ACC has a tendency for locally 
invasive growth and  perineural invasion with high  predilection for local recurrence 
and distant metastasis (1). 
Morphological diversity, cytological uniformity , an infiltrative growth pattern 
and low metastatic potential are essential characteristic features of polymorphous low 
grade adenocarcinoma (PLGA) which  is a malignant epithelial tumour of salivary 
gland(2). The confusion with adenoid cystic carcinoma and diagnostic trouble are due 
to morphologic heterogeneity. It is important and crucial to differentiate it from 
tumours with myoepithelial differentiation; adenoid cystic carcinoma (ACC) which 
consequently has this diagnostic challenge(3,4). A correlation between clinical 
progression and histologic characteristic has been documented; the papillary cystic 
pattern is now associated with aggressive clinical behavior. It has also been noted that 
this transformation phenomenon, like the clinical progression follows the course of 
time, and local recurrences (5). 
Type I membrane glycoprotein ,CD105 (Endoglin), situated on cell surfaces 
and is part of the TGF beta receptor complex. CD105 is an important protein for 
tumor growth, survival and metastasis of cancer cells to other locations in the body 
due to its  crucial role in angiogenesis  (6). 
 Nuclear protein, Ki-67, that is related with and may be essential for 
proliferation of cells and provided a reliable method for tumor growth rate 
evaluation(7,8). 
  Additionally it is connected with ribosomal RNA transcription. Inactivation 
of antigen Ki-67 leads to inhibition of ribosomal RNA synthesis (9). 
Aims of the our  study were to evaluate the immunohistochemical expression 
of CD105 and Ki-67 in adenoid cystic carcinoma and polymorphous low grade 
adenocarcinoma of the salivary glands and to correlate the immunoexpression of these 
proteins with the clinicopathological findings. 
     
Materials and Methods 
Sample 
         Salivary   gland malignancies  of  fifty patients   haphazardly selected from the 
file records and pathologic specimens from the archives of the department of oral   
diagnosis/   Collage   of   Dentistry/Baghdad University and the Maxillofacial Center 
in Al-Shaheed Ghazi Hospital in Baghdad dated from 1973 to 2015. 
       Patient's information concerning age, sex, site and clinical staging of the tumor 
that  represent the clinical data w e r e  c o l l e c t e d  f r o m  the case sheets presented 
with the tumor specimens.  We are evaluated  all the  clinical and histopathologic data 
to exclude cases representing secondary metastatic disease to the salivary gland . 
 
Control 
        Negative control was done  by primary antibody omitting step and addition of all 
other  reagents . Five normal salivary gland tissues were used as   negative external 
control at the same period of time. Nonexistence of specificity of the antibody 
presented as positive staining; according to ab cam manufacturer’s data sheets. Tonsil 
tissue were used as positive control for CD105 and Ki-67  
 
Immunohistochemical procedure  
          First of all was deparaffinization of 4µm sections in xylene and then 
rehydration of them in graded alcohol.  Then take the slides and add hydrogen 
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peroxide block drops and t h e n  incubation in humid chamber at 37C° for 10 
minutes was done, after that and for 5 minutes for each socked 2 times in buffer.  
Protein cross-links that mask antigenic places in tissue specimens occur due to 
formalin or other aldehyde fixation so that antigenicity reveal is very important so 
that  tissue retrieving is done to the slides. After that the slides incubated at 37°C for 
10 minutes after the adding of enough drops of protein block. Then washed 2 times in 
buffer this done by 5 minutes for each, draining  and blotting gently were done lastly.  
After that   each  slide exposed to  diluted  primary  antibody ,  incubated  in  humid 
chamber  at  37°C. overnight.  Next day, and in 4 times for each the slides were 
washed in buffer, lastly and as before the slides  drained and blotted gently. Now 
secondary antibody reagent drops were added and for 30 minutes at 37°C incubated 
in humid chamber .Next, and in 5 minutes for each one the slides were washed 4 
times in buffer, finally drained and blotted gently. After that Streptavidine-HRP 
an t ib od i es  w e r e  ap p l i ed  on tissue and incubated for 30 minutes at 37°C. Later  
in dark room diluted DAB was applied on tissue  and for 10 minutes at 37°C 
incubated in humid chamber.  Next slides washed carefully in tap water for 5 
minutes. Now   the  slides   were bathed   in   Hematoxylin counter stain for 1-2 
minutes then they were rinsed with tap water for 10 minutes. Then the slides were 
dehydrated by immersing them in ethanol and xylene containing jars.  One to two   
drops   of   DPX   mounting   medium   were applied next to the xylene wet sections 
and covered with cover slips and left overnight to dry.    
The results were evaluated by the presence of brown colored end product at 
the site of target antigen (cytoplasm) in CD 105 and the presence of brown colored 
end product at the site of target antigen (nucleus) in Ki-67 were  indicative of positive 
immunoreactivity.  Percentage of IHC positive tumor cells per hotspot was 
calculated and the mean percentage per slide was determined. Collection 10 high 
power field from the more representative area of immunostaining fields.  
       The intensity of stain because it’s subjected to individual variance during 
checking was ignored.   
      The immunoreactivity of CD105 was classified as follows: (score 0) (-ve) <10 
% of the   tumor   cells,   low   (score   I)   (+)   10 -25%, moderate (score II) (++) 
26-50%, h i g h  (score III) (+++) 51-100% of positive cells, depending on 
counting(10,11) 
      The immunoreactivity of Ki-67 was classified as follows: (score 0) (-ve) ≤ 5% 
of the   tumor   cells,   low (score  I)   (+)   6-25%, moderate (score II) (++) 26-50%, 
h i g h  (score III) (+++) 51-100 % of positive cells, depending on counting (12). 
        
Statistical analysis 
           In our study we tabulated and subjected the clinical, histopathological and 
immunohistochemical relevant data to appropriate statistical analysis using the SPSS 
v 20 software. We are scored and presented the studied parameters as count and 
percentage. 
          The relationship between categories was tested by  fisher's exact test. ANOVA 
test (analysis of variance) was used to detect differences for age and the marker. P 
value equal or less than 0.05 was considered to be statistically significant. 
 
Clinicopathological Finding  
CD105 immunoexpression  
        Tonsil tissue was used as positive control of CD105 which expressed as brown 
diffuse cytoplasmic immunoreactivity. 
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            Negative control was detected by omitting of primary antibody ,this is for 
testing the specificity of antibody used in our study , if positive staining occur this  
indicates a lack of specificity of the antibody . 
         Brown staining localized in the cytoplasm of the tumor cells mean CD105 
immunoreactivity  .CD105 expression was found positive in 21 cases of ACC and 20 
cases of PLGA in different scores  .The higher  percentage of  CD105 expression 
(score I) was found in 12 cases of ACC (48 %) and in 14 cases of PLGA (56 %).  
     Non- significant statistical relation (P= 0.802) was detected regarding CD105 
expression in both types of tumor as in table 1. 
     Non- significant statistical relation (P=>0.05) was detected regarding CD105 
expression in relation to sex, site and stage  in both types of tumor as in table 2. 
    Non- significant statistical relation (P=>0.05) was detected regarding CD105 
expression in relation grade  in ACC as in table 2. 
Table 1: CD105 scores in ACC and PLGA 
 
PLGA ACC CD105 score 
5  ( 20%) 4 ( 16  %) Score 0 
14 ( 56 %) 12 (48 %) Score 1 
6 ( 24 %) 8( 32 %) Score 2 
0 ( 0 %) 1 (4%) Score 3 
25 (100%) 25(100%) Total 
NS 
P value= 0.802   
 
Table 2: The clinicopathological finding of ACC and PLGA in relation to CD105 
expression 
P 
value 
PLGA 
No.25 
ACC 
No.25 
Variable 
CD105 CD105 
+ve -ve +ve -ve 
 57.6±15.950 42.20± 2.533 
 
 
AGE mean ±𝑆𝐷  
NS 
> 0.05 
 
10 
10 
0 
5 
14 
7 
2 
2 
Male 
Female 
SEX 
NS 
> 0.05 
15 
1 
1 
0 
0 
3 
4 
1 
0 
0 
0 
0 
15 
3 
0 
1 
1 
1 
2 
0 
0 
0 
1 
1 
 
Palate 
Floor of mouth                
Upper lip 
Check 
Submandibular gland 
others 
 
SITE 
NS 
> 0.05 
4 
8 
4 
4 
4 
0 
0 
0 
8 
9 
2 
2 
3 
1 
0 
0 
I 
II 
III 
IV 
STAGE 
NS 
> 0.05 
 
- 
- 
- 
5 
12 
4 
 
2 
3 
2 
I(tubular ) 
II(cribriform) 
III(solid) 
GRADE 
 0 0 2 0 PERINEURAL  INVATION 
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Ki-67 immunoexpression 
        Brown nuclear and nucleolar  immunoreactivity of Ki-67 was expressed in tonsil 
tissue which is  positive control in our study. 
        Omitting of primary antibody were used as negative control ,this is for testing the 
specificity of antibody used in our study ,positive staining indicates a lack of 
specificity of the antibody . 
           Ki-67 immunoreactivity was noticed as brown staining localized in the uncles 
and nucleolus  of the tumor cells .Ki-67 expression was found positive in 24 cases of 
ACC and 23 cases of PLGA  in different scores.The higher  percentage of Ki-67 
expression and  (score I) was found in  12 cases of ACC (48%) and  (scores  I & III) 
was found in 9 cases of  PLGA (36%). 
        Non- significant statistical relation (P=0.852) was detected regarding Ki-67 
expression in both types of tumor as in table 3 . 
     Non- significant statistical relation (P=>0.05) was detected regarding Ki-
67expression in relation to sex, site and stage  in both types of tumor as in table 4. 
    Non- significant statistical relation (P=>0.05) was detected regarding Ki-67 
expression in relation grade  in ACC as in table 4. 
 
Table 3: Ki-67 scores in ACC and PLGA 
 
PLGA ACC Ki-67 
score 
2 ( 8 %) 1 ( 4%) Score 0 
9( 36 %) 12  ( 48%) Score 1 
5  ( 20%) 5 ( 20 %) Score 2 
9 ( 36 %) 7  ( 28 %) Score 3 
25 (100 %) 25 (100 %) Total 
NS 
P value= 0.852 
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Table 4: The clinicopathological finding of ACC and PLGA in relation to Ki-67 
expression 
 
P 
value 
PLGA 
No.25 
ACC 
No.25 
Variable 
Ki-67 
 
Ki-67 
 
+ve -ve +ve -ve 
 57.6±15.950 42.20± 2.533 
 
AGE mean ±𝑆𝐷  
NS 
> 0.05 
9 
14 
1 
1 
15 
9 
1 
0 
Male 
Female 
SEX 
 
NS 
> 0.05 
19 
1 
1 
0 
0 
2 
0 
1 
0 
0 
0 
1 
16 
3 
0 
1 
2 
2 
1 
0 
0 
0 
0 
0 
 
Palate 
Floor of mouth                
Upper lip 
Check 
Submandibular gland 
others 
 
SITE 
NS 
> 0.05 
7 
9 
4 
3 
1 
0 
0 
1 
10 
10 
2 
2 
1 
0 
0 
0 
I 
II 
III 
IV 
STAGE 
NS 
> 0.05 
 
- 
- 
- 
5 
14 
5 
 
1 
0 
0 
I(tubular ) 
II(cribriform) 
III(solid) 
GRADE 
 0 0 2 0 PERINEURAL  INVATION 
 
 
Discussion 
        Our study is constantly attempted to emphasis largely on finding 
immunohistochemical differences between ACC and PLGA, mostly in the cribriform 
histology, common to both tumours, we confirm a diagnostic marker for histological 
resemblance by trying to use immunohistochemistry.  In this study we compared Ki-
67 protein expression in adenoid cystic carcinoma and polymorphous low grade 
adenocarcinoma. 
         Ki-67 marker  play an important role in  tumor development ,progression and in 
the overall prognosis . However the action of this molecule  functioning   has yet to be 
defined. The role of Ki-67 in ACC and PLGA has not been revealed adequately. 
          The results of this study showed that  high - grade tumors characterized by 
overexpression of Ki-67 was overexpressed in the advanced - stage disease .These 
finding led us to believe that  Ki-67 might be used as biomarkers for aggressive 
disease manners and as predictor of poor overall survival.   
         It is also worth noting that  Ki-67 expression was not detected (1 and 2 cases) of 
tumor specimens of ACC and  PLGA respectively .  One possible explanation of this 
findings is that expression of  Ki-67  may possibly be occur  in ACC and PLGA but 
occasionally its production is unsteady and preserved at almost unnoticeable levels.          
        . 
          On the other hand, Ki-67 examination indicated that its expression was useful 
for differentiation of ACC from PLGA . Ki-67 was expressed around the duct more 
intense than other markers. An increase in Ki-67 expression indicates an increase in 
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mitotic cell activity and proliferation . The growth fraction determination of cell 
population was done by Ki-67 which  is an excellent marker . 
         In our study ,due to unavailability of information associated with prognosis 
,survival and follow up of the patients ,it was impossible to assess the relationship 
between Ki-67 marker and factors associated with prognosis.        
         Ki-67expression  in different studies show variance, this  may be related to the  
type of antibody used (monoclonal and polyclonal) , and the differences in how the 
cells are counted  
           
       The nuclear distribution of the immunohistochemical staining product was found 
to be granular, diffuse, or a combination of both. This finding is in agreement with 
previous reports in which the staining sites have been accurately determined at an 
ultrastructural level and which have also demonstrated variations of the granular and 
diffuse staining patterns in the various phases of proliferation  ( 13,14,15,16,17) We 
found that the diffuse staining pattern was generally strongly or moderately intense, 
whereas the granular pattern could show the whole spectrum of intensities. 
 
Conclusion 
         The tumor  Ki-67 staining  play a vital role  to evaluate patients at high risk of 
tumor progression but cannot consider as   independent prognostic factors.    
             
        Ki-67 mean of expression  was higher in ACC than  PLGA which indicates 
higher malignant potential .  
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 ةصلاخلا 
 ديهمت  
       ةيجيسنلا  طامنلاا نم ددع  يف لخادت امهلو  ةئطاولا ةجردلا وذ لاكشلاا ددعتملا يدغلا ناطرسلاو يدغلا يسيكلا ناطرسلا
.مصلااو يبوبنلاا ،بقثملا لمشت يتلاو ةيضرملاو ةيريرسلا تافصلا لخادت نا ددعتملا يدغلا ناطرسلاو يدغلا يسيكلا ناطرسلل 
ةئطاولا ةجردلا وذ لاكشلاا دغلا يسيكلا ناطرسلا نا .قزام يف صيخشتلا لعج ىلا يدايضرملا روطت يف اوسا هناب زاتمي ي  نم
لج لا يرورض امهنيب زييمتلا لعجي اذهو ةئطاولا ةجردلا وذ لاكشلاا ددعتملا يدغلا ناطرسلا باتمو  جلاعلاضرملا روطت ةع. 
فادهلاا 
         لل يعانملا يجيسنلا يئايميكلا روهظلا مييقتCD105. .رثاكتلا رشؤموKi-67 يدغلا ناطرسلاو يدغلا يسيكلا ناطرسلل .
ذ لاكشلاا ددعتملاةيباعللا ددغلل ةئطاولا ةجردلا و، اوعلا هذه روهظ ةجرد ةنراقموةيضرملاو ةيريرسلا صئاصخلا عم لم. 
 داوملالمعلا قئارطو 
       ةساردلا تنمضت50  ةنيعلانيباصم صاخش ةيباعللا ددغلا ناطرسب ،25  نيباصم صاخش لا هنيع يدغلا يسيكلا ناطرسلاب
و25 لا يدغلا ناطرسلاب نيباصم صاخش لا ةنيعةئطاولا ةجردلا وذ لاكشلاا ددعتم مفلا ضارما مسق فيشرا نم تانيعلا هذه تعمج ،
 ولك /نيكفلاو هجولانانسلاا بط ةي/  ربتخمو دادغب ةعماجةماعلا ضارملاا/ ديهشلا ىفشتسم ةيصصختلا تاحارجلل يريرحلا يزاغ ،
 5102 rebmetpeS ,)3(72 .loV
 9102 :)3( .oN ,)72( .loV ,secneicS deilppA dna eruP ,nolybaB fo ytisrevinU fo lanruoJ
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وباستخدام قوالب شمعيه حاوية على النسيج المحفوظ في الفور مالين واجري لها الفحص النسيجي للتأكد من التشخيص بعد تقطيعها 
 ما يكرو متر. 4الى شرائح دقيقة وبسمك 
.للشرائح النسيجية بنفس  76-iK ومؤشر التكاثر   501 DCبعدها تم اجراء الفحوصات المناعية النسيجية الكيميائية لل.       
السمك المذكور سابقا مع اجراء اختبار السيطرة السالبة والموجبة  ثم تقييم النتائج الى بعضها البعض والى الخصائص السريرية 
 .اوالمرضية ايض
 النتائج
 02عينة للسرطان الكيسي الغدي و  12موجبا في   كان DC501اظهرت النتائج ان الظهور  الكيميائي النسيجي  المناعي لل.      
عينة للسرطان الغدي المتعدد الاشكال ذو الدرجة الواطئة كما اظهرت النتائج ان الظهور  الكيميائي النسيجي  المناعي لمؤشر 
 عينة للسرطان الغدي المتعدد الاشكال ذو الدرجة الواطئة . 32عينة للسرطان الكيسي الغدي 42  موجبا في كان  iK-76التكاثر
 .متعدد الاشكال ذو الدرجة الواطئةفي السرطان الكيسي الغدي والسرطان الغدي ال  501DCلوحظ عدم وجود علاقة معنوية لل.       
. في السرطان الكيسي الغدي والسرطان الغدي المتعدد الاشكال ذو 76-iKلوحظ عدم وجود علاقة معنوية لمؤشر التكاثر        
 الدرجة الواطئة.
مع جنس المريض والموقع التشريحي ومكان تحديد   76-iK. ومؤشر التكاثر501DCلوحظ عدم وجود علاقة معنوية لل         
 الدرجة الواطئة. الانتشار في السرطان الكيسي الغدي و السرطان الغدي المتعدد الاشكال ذو
 مع درجة التمايز في السرطان الكيسي الغدي.   76-iK. ومؤشر التكاثر501DCلوحظ عدم وجود علاقة معنوية لل         
 الاستنتاجات
تلعب دور مهم في تقييم المرض ولا يمكن اعتبارها غير مهمة   76-iKومؤشر التكاثر  501DCفي هذه الدراسة ظهر ان ال        
 ل تقييم المرض. في مجا
ان الاختلاف في الميل البيولوجي ليس له علاقه مع تكوين اوعيه دموية جديدة، ان زباده تكوين الأوعية الدموية يتناسب طرديا مع  
في سرطانات الغدد اللعابية يظهر دوره في تطور السرطانات الخبيثة ودور خلايا  501DCتكون السرطانات الخبيثة ان ظهور ال 
 في السيطرة على تكوين اوعية دموية جديدة  .  llec lailehtipeoyMال
 يكون في السرطان الكيسي الغدي اكثر من السرطان الغدي المتعدد الاشكال ذو الدرجة الواطئة.           76-iKان نسبة ظهور مؤشر التكاثر 
رطان الغدد اللعابية وتساهم في تنظيم عمليات هذا التداخل والتفاعل يحفز عمليات بخطوات متعددة تساعد على حدوث س        
 الهجوم والنزعة الخبيثة  لهذه السرطانات.
لسرطان الغدي المتعدد الاشكال ذو الدرجة الواطئة، الظهور الكيميائي النسيجي االسرطان الكيسي الغدي،  لدالة:الكلمات ا
 .  76-iK. مؤشر التكاثر501DCالمناعي،
 
